Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

WHITIA Unveils Remi-d

To provide remote-operated X-ray screening in HIV and TB co-epidemic diseases

The World Health Imaging, Telemedicine and Informatics Alliance (WHITIA) has unveiled Remi-d, a new product concept that is intended to provide remote-operated X-ray capabilities for use in screening across areas of the developing world experiencing the Human Immunodeficiency Virus (HIV) and Tuberculosis (TB) co-epidemic, high incidences of Black Lung disease, or outbreaks of other infectious respiratory diseases.

Remi-d is a remote-controlled, self-contained, digital medical X-ray device intended to meet the imaging needs of resource-limited areas such as sub-Saharan Africa, South and Central America and Southeast Asia, where radiologists and technologists are in short supply.

Remi-d is intended to provide advanced capabilities including, automated patient experience via a computer interface that allows patients to self-manage the multi-lingual capable registration process and retrieve results.

Also includes teleradiography, through which a remote X-ray technologist can position patients and operate the X-ray equipment, avatar/patient interaction providing a digital representation of the remote technologist in the booth to guide the patient through the X-ray process. Teleradiology is also included which sends Remi-d’s images to remote radiologists for interpretation and diagnosis.

The company said that WHITIA partnered with Merge Healthcare and Sedecal to develop Remi-d with the shared goal of deploying the systems worldwide and providing millions of people with the opportunity to receive life-saving health screenings.

Ivy Walker, chief executive officer of WHITIA, said: “When Remi-d’s development has been completed and the device has been approved, we hope to make a significant difference in the screening of diseases worldwide.

“With the support of partners such as Merge Healthcare and others, WHITIA is well-positioned to continue Remi-d’s development and to provide support to sustain the systems when they are ready to be deployed. With ongoing partner and solution development, we believe Remi-d, if approved, could be a leader in remote medical imaging.”

Justin Dearborn, chief executive officer of Merge Healthcare, said: “We are extremely pleased to work with WHITIA on this important concept for better global access to diagnostic imaging.

“Over the course of our partnership, we have seen many of the human resource and technical barriers to imaging access experienced by developing communities, and Remi-d is intended to specifically address these very issues. We are proud of the role our technology plays with this new and potentially game changing concept.”